SecBot SecBot

NYXH

Nyxoah SA
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. C9· CIK 0001857190 Healthcare & Medical Devices
$0.9110 +0.06 (+6.43%)
Oct 27 4:00 PM ET · prev $0.8560
Market cap
$83.5M
Micro cap
Consensus
Buy
77% Buy or better · 13 analysts
Median target
🔒 Subscribers only
1 year
−81.8%
from $5.01 · Oct 28
30 days
−42.7%
from $1.59
52-week range
$0.8220–5.89
−85% from high · low Oct 22
Avg volume 20D
213.2K
Oct 22 spike 643.7K
Short interest
213.6K
≈0.2% of shares · −33.7%
Days to cover
2.1
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
10
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 2 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 3/3
Strongest BEARISH Nyxoah reported preliminary Q3 2026 global net revenue of €9.2 million (up 19% sequentially) and U.S. net…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 3 added (0 new), 1 trimmed or exited.

  • AnalystsBULLISH

    10 of 13 rate it Buy or better.

  • Short sellersCOVERING

    Short interest −33.7% to 213.6K shares. 2.1 days to cover, ≈0.2% of shares.

  • TrendDOWNTREND

    35% below its 50-day average. New closing low $0.8220 on Oct 22.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BNP Paribas Asset Management Holding S.A.ADD962,524$1.7M
BlackRock, Inc.NEAR_EXIT121,207$204.8K
GEODE CAPITAL MANAGEMENT, LLCDOUBLED44,802$75.7K
MORGAN STANLEYADD4,475$7.6K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

13 analysts
Buy 77% rate it Buy or better
Strong Buy4Buy6Hold3Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 27, 2026🔒 Fresh data, subscribers only
MAINTAIN
MAINTAIN
Aug 17, 2026Cantor Fitzgerald
MAINTAIN
MAINTAINOverweight
Aug 6, 2026Piper Sandler
REITERATE
REITERATEOverweight
Jun 17, 2026Stifel
MAINTAIN
MAINTAINHold
May 13, 2026Piper Sandler
REITERATE
REITERATEOverweight
May 12, 2026Stifel
DOWNGRADE
DOWNGRADEHold

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 26, 2026
Earnings
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
Oct 19, 2026
Earnings
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026…
Oct 15, 2026
Press release
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026
Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026 Genio® bilateral stimulation...
Sep 28, 2026
Press release
Nyxoah Appoints Liam Kelly as Chief Executive Officer
REGULATED INFORMATION INSIDE INFORMATION
Sep 21, 2026
Press release
Nyxoah Announces Chief Financial Officer Transition
REGULATED INFORMATION INSIDE INFORMATION

Short side

FINRA· Oct 15, 2026
213,619
shares short
-33.7%
vs prior settlement
2.1
days to cover
≈0.2%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 Earnings
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
Oct 20, 2026 SEC
Nyxoah reported preliminary Q3 2026 global net revenue of €9.2 million (up 19% sequentially) and U.S. net revenue of…
6-K — Impact 6/10
Oct 19, 2026 SEC
Nyxoah reported preliminary Q3 2026 global net revenue of €9.2M (19% sequential growth) and U.S. net revenue of €6.7M…
PRESS-RELEASE — Impact 6/10
Sep 22, 2026 SEC
Nyxoah announced CFO John Landry will step down effective October 2, 2026, with President International and former CFO…
6-K — Impact 3/10
Jun 30, 2026 Inst.
BNP Paribas Asset Management — ADD
962,524 shares ($1.7M)
Jun 30, 2026 Inst.
BlackRock, Inc. — NEAR_EXIT
121,207 shares ($204.8K)
Jun 5, 2026 Press
Nyxoah priced a $95M underwritten public offering of ~55.2M shares at $1.72/share, a ~24% discount to the prior close…
Impact 7/10
Mar 19, 2026 Press
Nyxoah reported strong fourth-quarter and full-year 2025 financial results, driven by the first full quarter of U.S…
Impact 8/10

SecBot reports

10 filings · 3 press releases · 1 bullish · 7 bearish · 1 mixed · 1 neutral
All NYXH filing & press-release reports (13)